Arcus Biosciences, Inc. — Director's Dealing 2019

Oct 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2019-10-10

Reporting Person: Grossman William (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-10	Common Stock	P	100	$8.00	Acquired	100	Direct
2019-10-14	Common Stock	P	300	$8.00	Acquired	400	Direct